Biolife Solutions (BLFS) Gains from Investment Securities (2011 - 2026)
Biolife Solutions (BLFS) reported Gains from Investment Securities of $5.6 million for Q1 2026, up 50900.0% quarter-over-quarter from -$11000.0 in Q4 2025.
Biolife Solutions (BLFS) Gains from Investment Securities (2011 - 2026) Analysis & Trends
Biolife Solutions (BLFS) has 15 years of Gains from Investment Securities data on file, last reported at $5.6 million in Q1 2026.
- Gains from Investment Securities for Q1 2026 came in at $5.6 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $5.6 million (up 234.84% YoY), and the FY2025 annual result was -$11000.0, up 99.73% from the prior year.
- Gains from Investment Securities advanced to $5.6 million in Q1 2026 per BLFS's latest filing, from -$11000.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $5.6 million in Q1 2026 and troughed at -$4.1 million in Q4 2024.
- A 5-year average of -$260842.0 and a median of -$415000.0 in 2023 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2023 and 2024: Gains from Investment Securities soared 108.06% in 2023, then sank 896.63% in 2024.
- A 5-year view of Gains from Investment Securities shows it stood at -$691000.0 in 2022, then soared by 39.94% to -$415000.0 in 2023, then slumped by 896.63% to -$4.1 million in 2024, then soared by 99.73% to -$11000.0 in 2025, then surged by 50900.0% to $5.6 million in 2026.
- Business Quant data shows BLFS's Gains from Investment Securities at $5.6 million in Q1 2026, -$11000.0 in Q4 2025, and -$4.1 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Biolife Solutions | 1.27 Bn | 1.19 Bn | 17.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.59 Mn |
| Mar 31, 2026 | 5.59 Mn |
| Dec 31, 2025 | -11,000.00 |
| Dec 31, 2025 | -11,000.00 |
| Dec 31, 2024 | -4.14 Mn |
| Dec 31, 2024 | -4.14 Mn |
| Mar 31, 2024 | 14,000.00 |
| Mar 31, 2024 | 14,000.00 |
| Dec 31, 2023 | -415,000.00 |
| Dec 31, 2023 | -415,000.00 |
| Sep 30, 2023 | -1.58 Mn |
| Sep 30, 2023 | -1.58 Mn |
| Jun 30, 2023 | -918,000.00 |
| Jun 30, 2023 | -918,000.00 |
| Mar 31, 2023 | 268,738.00 |
| Mar 31, 2023 | 268,738.00 |
| Dec 31, 2022 | -691,000.00 |
| Dec 31, 2022 | -691,000.00 |
| Sep 30, 2022 | 2.35 Mn |
| Sep 30, 2022 | 2.35 Mn |